FOXO6 is a member of the forkhead box O (FOXO) subfamily of transcription factors, which includes four mammalian members: FOXO1, FOXO3, FOXO4, and FOXO6 1. FOXO6 functions as a DNA-binding transcription factor that regulates cellular processes including apoptosis, oxidative stress, autophagy, cell cycle control, and inflammation 2. Unlike other FOXO proteins, FOXO6 exhibits unique regulatory mechanisms, particularly its inability to undergo classical nucleocytoplasmic shuttling 2. FOXO6 plays a critical role in hepatic glucose metabolism, with its activity remaining low in fed states but becoming markedly induced during fasting 3. In disease contexts, FOXO6 activity becomes abnormally elevated in obesity and type 2 diabetes, contributing to glucose intolerance, fasting hyperglycemia, and hyperinsulinemia 3. Insulin inhibits FOXO6 activity through phosphorylation, disabling its nuclear function without altering subcellular distribution 3. FOXO6 has emerged as a potential therapeutic target for metabolic disorders and diabetic complications 42. The protein interacts with critical signaling pathways including PI3K/Akt, PPARγ, and TXNIP, and its dysregulation has been implicated in various diseases beyond diabetes, including cancer and neurodegenerative conditions 2.